197 related articles for article (PubMed ID: 19110314)
21. Oxidative stress in toadfish (Halobactrachus didactylus) cardiac muscle. Acute exposure to vanadate oligomers.
Aureliano M; Joaquim N; Sousa A; Martins H; Coucelo JM
J Inorg Biochem; 2002 Jun; 90(3-4):159-65. PubMed ID: 12031809
[TBL] [Abstract][Full Text] [Related]
22. Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?
Aureliano M
Oxid Med Cell Longev; 2016; 2016():6103457. PubMed ID: 26904166
[TBL] [Abstract][Full Text] [Related]
23. Recent perspectives into biochemistry of decavanadate.
Aureliano M
World J Biol Chem; 2011 Oct; 2(10):215-25. PubMed ID: 22031844
[TBL] [Abstract][Full Text] [Related]
24. Decavanadate as a biochemical tool in the elucidation of muscle contraction regulation.
Tiago T; Aureliano M; Moura JJ
J Inorg Biochem; 2004 Nov; 98(11):1902-10. PubMed ID: 15522416
[TBL] [Abstract][Full Text] [Related]
25. Decavanadate Inhibits Mycobacterial Growth More Potently Than Other Oxovanadates.
Samart N; Arhouma Z; Kumar S; Murakami HA; Crick DC; Crans DC
Front Chem; 2018; 6():519. PubMed ID: 30515375
[No Abstract] [Full Text] [Related]
26. Electronic properties of a cytosine decavanadate: toward a better understanding of chemical and biological properties of decavanadates.
Bosnjaković-Pavlović N; Spasojević-de Biré A; Tomaz I; Bouhmaida N; Avecilla F; Mioc UB; Pessoa JC; Ghermani NE
Inorg Chem; 2009 Oct; 48(20):9742-53. PubMed ID: 19764781
[TBL] [Abstract][Full Text] [Related]
27. Raft localization of type I Fcε receptor and degranulation of RBL-2H3 cells exposed to decavanadate, a structural model for V2O5.
Al-Qatati A; Fontes FL; Barisas BG; Zhang D; Roess DA; Crans DC
Dalton Trans; 2013 Sep; 42(33):11912-20. PubMed ID: 23861175
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.
Willsky GR; White DA; McCabe BC
J Biol Chem; 1984 Nov; 259(21):13273-81. PubMed ID: 6386812
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro.
Turner TL; Nguyen VH; McLauchlan CC; Dymon Z; Dorsey BM; Hooker JD; Jones MA
J Inorg Biochem; 2012 Mar; 108():96-104. PubMed ID: 22005446
[TBL] [Abstract][Full Text] [Related]
30. The future of/for vanadium.
Rehder D
Dalton Trans; 2013 Sep; 42(33):11749-61. PubMed ID: 23567506
[TBL] [Abstract][Full Text] [Related]
31. Effect of vanadium ions on ATP citrate lyase.
Krivánek J
Gen Physiol Biophys; 1994 Feb; 13(1):43-55. PubMed ID: 8088501
[TBL] [Abstract][Full Text] [Related]
32. Influence of decavanadate clusters on the rheological properties of gelatin.
Carn F; Djabourov M; Coradin T; Livage J; Steunou N
J Phys Chem B; 2008 Oct; 112(40):12596-605. PubMed ID: 18795771
[TBL] [Abstract][Full Text] [Related]
33. Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP.
Sciortino G; Aureliano M; Garribba E
Inorg Chem; 2021 Jan; 60(1):334-344. PubMed ID: 33253559
[TBL] [Abstract][Full Text] [Related]
34. Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects.
Domingo JL
Biol Trace Elem Res; 2002 Aug; 88(2):97-112. PubMed ID: 12296430
[TBL] [Abstract][Full Text] [Related]
35. Pt
Kostenkova K; Arhouma Z; Postal K; Rajan A; Kortz U; Nunes GG; Crick DC; Crans DC
J Inorg Biochem; 2021 Apr; 217():111356. PubMed ID: 33582396
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of fluoride-incorporated polyoxovanadates.
Kikukawa Y; Yokoyama T; Kashio S; Hayashi Y
J Inorg Biochem; 2015 Jun; 147():221-6. PubMed ID: 25771147
[TBL] [Abstract][Full Text] [Related]
37. Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor.
Pluskey S; Mahroof-Tahir M; Crans DC; Lawrence DS
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):333-9. PubMed ID: 9020863
[TBL] [Abstract][Full Text] [Related]
38. A vanadium-51 NMR study of the binding of vanadate and peroxovanadate to proteins.
Rehder D; Casný M; Grosse R
Magn Reson Chem; 2004 Sep; 42(9):745-9. PubMed ID: 15307055
[TBL] [Abstract][Full Text] [Related]
39. Polyvanadate-stimulated NADH oxidation by plasma membranes--the need for a mixture of deca and meta forms of vanadate.
Kalyani P; Ramasarma T
Arch Biochem Biophys; 1992 Sep; 297(2):244-52. PubMed ID: 1497344
[TBL] [Abstract][Full Text] [Related]
40. Interaction of decavanadate polyanions with proteins.
Ashraf SM; Rajesh ; Kaleem S
Anal Biochem; 1995 Sep; 230(1):68-74. PubMed ID: 8585632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
